[Friedreich ataxia. 3 years after the identification of the gene a glimmer of hope for therapy].
von Kleist-Retzow
J C
JC
Unité de Recherches sur les Handicaps Génétiques de l'Enfant, INSERM U-393, Paris.
Chantrel-Groussard
K
K
Rötig
A
A
Munnich
A
A
Rustin
P
P
D000154:Aconitate Hydratase / Q000378:metabolism; D000975:Antioxidants / Q000627:therapeutic use; D016227:Benzoquinones / Q000627:therapeutic use; D005621:Friedreich Ataxia / Q000235:genetics / Q000628:therapy*; D006801:Humans; D007501:Iron / Q000378:metabolism; D033862:Iron-Binding Proteins; D008928:Mitochondria / Q000378:metabolism; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000502:physiology; D014451:Ubiquinone / Q000031:analogs & derivatives; D000096923:Frataxin
D000154:Aconitate Hydratase; D000975:Antioxidants; D016227:Benzoquinones; D007501:Iron; D033862:Iron-Binding Proteins; D017853:Phosphotransferases (Alcohol Group Acceptor); D014451:Ubiquinone; D000096923:Frataxin; C036619:idebenone